Treatment of Stage III Resectable Melanoma—Adjuvant and Neoadjuvant Approaches
AA Tarhini, E Castellano, I Eljilany - The Cancer Journal, 2024 - journals.lww.com
Patients with stage III resectable melanoma carry a high risk of melanoma recurrence that
ranges from approximately 40% to 90% at 5 years following surgical management alone …
ranges from approximately 40% to 90% at 5 years following surgical management alone …
Treatment of Stage III Resectable Melanoma—Adjuvant and Neoadjuvant Approaches
AA Tarhini, E Castellano, I Eljilany - The Cancer Journal, 2024 - journals.lww.com
Patients with stage III resectable melanoma carry a high risk of melanoma recurrence that
ranges from approximately 40% to 90% at 5 years following surgical management alone …
ranges from approximately 40% to 90% at 5 years following surgical management alone …
Treatment of Stage III Resectable Melanoma-Adjuvant and Neoadjuvant Approaches.
AA Tarhini, E Castellano, I Eljilany - Cancer Journal (Sudbury, Mass …, 2024 - europepmc.org
Patients with stage III resectable melanoma carry a high risk of melanoma recurrence that
ranges from approximately 40% to 90% at 5 years following surgical management alone …
ranges from approximately 40% to 90% at 5 years following surgical management alone …
Treatment of Stage III Resectable Melanoma-Adjuvant and Neoadjuvant Approaches
AA Tarhini, E Castellano… - … journal (Sudbury, Mass …, 2024 - pubmed.ncbi.nlm.nih.gov
Patients with stage III resectable melanoma carry a high risk of melanoma recurrence that
ranges from approximately 40% to 90% at 5 years following surgical management alone …
ranges from approximately 40% to 90% at 5 years following surgical management alone …